Skip to content
Future MDMA Treatment Following FDA's Rejection episode artwork

Sep 13, 2024 24 min

Future MDMA Treatment Following FDA's Rejection

from Cato Podcast

The FDA's rejection of MDMA as a treatment may well be a short-term setback for legally helping people with PTSD and other disorders. Mason Marks of Harvard Law School’s Petrie-Flom Center for Health Law Policy offers his assessment.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Future MDMA Treatment Following FDA's Rejection

0:00 24:10

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Cato Podcast?

This episode is 24 minutes long.

When was this Cato Podcast episode published?

This episode was published on September 13, 2024.

Can I download this Cato Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.